Yorktown Management & Research Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$404K | – | 302 |
|
|
2019
Q1 | $404K | Hold |
10,000
| – | – | 0.13% | 184 |
|
|
2018
Q4 | $380K | Sell |
10,000
-8,800
| -47% | -$334K | 0.13% | 170 |
|
|
2018
Q3 | $744K | Sell |
18,800
-20,000
| -52% | -$791K | 0.22% | 125 |
|
|
2018
Q2 | $1.36M | Hold |
38,800
| – | – | 0.4% | 60 |
|
|
2018
Q1 | $1.36M | Buy |
38,800
+28,800
| +288% | +$1.01M | 0.4% | 60 |
|
|
2017
Q4 | $347K | Hold |
10,000
| – | – | 0.1% | 220 |
|
|
2017
Q3 | $339K | Hold |
10,000
| – | – | 0.09% | 184 |
|
|
2017
Q2 | $341K | Hold |
10,000
| – | – | 0.11% | 106 |
|
|
2017
Q1 | $311K | Hold |
10,000
| – | – | 0.08% | 146 |
|
|
2016
Q4 | $273K | Buy |
10,000
+3,600
| +56% | +$98.3K | 0.07% | 181 |
|
|
2016
Q3 | $210K | Buy |
+6,400
| New | +$210K | 0.05% | 253 |
|
|
2016
Q1 | – | Sell |
-46,400
| Closed | -$1.58M | – | 364 |
|
|
2015
Q4 | $1.58M | Hold |
46,400
| – | – | 0.28% | 116 |
|
|
2015
Q3 | $1.48M | Hold |
46,400
| – | – | 0.24% | 147 |
|
|
2015
Q2 | $1.48M | Buy |
46,400
+40,000
| +625% | +$1.27M | 0.26% | 102 |
|
|
2015
Q1 | $219K | Hold |
6,400
| – | – | 0.04% | 411 |
|
|
2014
Q4 | $225K | Hold |
6,400
| – | – | 0.05% | 352 |
|
|
2014
Q3 | $229K | Hold |
6,400
| – | – | 0.04% | 360 |
|
|
2014
Q2 | $238K | Hold |
6,400
| – | – | 0.04% | 364 |
|
|
2014
Q1 | $208K | Sell |
6,400
-1,600
| -20% | -$52K | 0.04% | 419 |
|
|
2013
Q4 | $237K | Hold |
8,000
| – | – | 0.05% | 326 |
|
|
2013
Q3 | $208K | Buy |
+8,000
| New | +$208K | 0.04% | 322 |
|